DBV Technologies SA (DBVT)
9.11
+0.24
(+2.71%)
USD |
NASDAQ |
Oct 15, 16:00
9.10
-0.01
(-0.11%)
After-Hours: 20:00
DBV Technologies Cash from Operations (TTM) : -169.35M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -169.35M |
| March 31, 2026 | -151.29M |
| December 31, 2025 | -121.68M |
| September 30, 2025 | -98.74M |
| June 30, 2025 | -88.84M |
| March 31, 2025 | -89.45M |
| December 31, 2024 | -104.47M |
| September 30, 2024 | -105.91M |
| June 30, 2024 | -103.02M |
| March 31, 2024 | -93.50M |
| Date | Value |
|---|---|
| December 31, 2023 | -79.65M |
| September 30, 2023 | -89.85M |
| June 30, 2023 | -90.33M |
| March 31, 2023 | -75.03M |
| December 31, 2022 | -55.67M |
| September 30, 2022 | -46.22M |
| June 30, 2022 | -49.13M |
| March 31, 2022 | -69.17M |
| December 31, 2021 | -103.90M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Cellectis SA | -42.00M |
| Akari Therapeutics Plc | -10.74M |
| EDAP TMS SA | -- |
| Bicycle Therapeutics Plc | -205.24M |
| Autolus Therapeutics Plc | -224.98M |